Literature DB >> 6407303

The prognosis of hyperlysinemia: an interim report.

J Dancis, J Hutzler, M G Ampola, V E Shih, H H van Gelderen, L T Kirby, N C Woody.   

Abstract

Ten patients with familial hyperlysinemia with lysine-ketoglutarate reductase deficiency, identified through newborn screening programs or family surveys, were selected for review. Ages ranged from 2 to 24 years when last examined. A low-protein diet had been administered to two patients, which reduced the plasma lysine levels from 20 mg per dl or more to about 12 mg per dl. The rest were untreated. Mental development was judged normal or above average in nine. Mildly subnormal performance in three was considered appropriate to family and social background. No adverse mental or physical effects could be attributed to the hyperlysinemia. A normal child has been born to a mother with hyperlysinemia, indicating that the fetus may develop normally despite exposure to high lysine levels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407303      PMCID: PMC1685659     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  12 in total

1.  Multiple enzyme defects in familial hyperlysinemia.

Authors:  J Dancis; J Hutzler; N C Woody; R P Cox
Journal:  Pediatr Res       Date:  1976-07       Impact factor: 3.756

2.  Routine newborn screening for histidinemia. Clinical and biochemical results.

Authors:  H L Levy; V E Shih; P M Madigan
Journal:  N Engl J Med       Date:  1974-12-05       Impact factor: 91.245

3.  Hyperlysinaemia. Harmless inborn error of metabolism?

Authors:  H H van Gelderen; H L Teijema
Journal:  Arch Dis Child       Date:  1973-11       Impact factor: 3.791

4.  Hyperlysinemia associated with retardation.

Authors:  H Ghadimi; V I Binnington; P Pecora
Journal:  N Engl J Med       Date:  1965-09-30       Impact factor: 91.245

5.  Transfer of amino acids across the in vitro perfused human placenta.

Authors:  H Schneider; K H Möhlen; J Dancis
Journal:  Pediatr Res       Date:  1979-04       Impact factor: 3.756

6.  A case of hyperlysinemia: biochemical and clinical observations.

Authors:  M D Armstrong; M Robinow
Journal:  Pediatrics       Date:  1967-04       Impact factor: 7.124

7.  Further studies of hyperlysinemia.

Authors:  N C Woody; J Hutzler; J Dancis
Journal:  Am J Dis Child       Date:  1966-12

8.  Amino acid pools in the feto-maternal system.

Authors:  A Velázquez; A Rosado; A Bernal; L Noriega; N Arévalo
Journal:  Biol Neonate       Date:  1976

9.  Familial hyperlysinemia with lysine-ketoglutarate reductase insufficiency.

Authors:  J Dancis; J Hutzler; R P Cox; N C Woody
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  Familial hyperlysinemia: enzyme studies, diagnostic methods, comments on terminology.

Authors:  J Dancis; J Hutzler; R P Cox
Journal:  Am J Hum Genet       Date:  1979-05       Impact factor: 11.025

View more
  10 in total

1.  Dietary treatment of hyperlysinaemia.

Authors:  J W Gregory; N Beail; N A Boyle; C Dobrowski; P Jackson
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

2.  The significance of hyperpipecolatemia in Zellweger syndrome.

Authors:  J Dancis; J Hutzler
Journal:  Am J Hum Genet       Date:  1986-05       Impact factor: 11.025

3.  DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo.

Authors:  João Leandro; Tetyana Dodatko; Jan Aten; Natalia S Nemeria; Xu Zhang; Frank Jordan; Ronald C Hendrickson; Roberto Sanchez; Chunli Yu; Robert J DeVita; Sander M Houten
Journal:  Hum Mol Genet       Date:  2020-05-08       Impact factor: 6.150

4.  Selective screening for amino acid disorders.

Authors:  M Duran; L Dorland; P K de Bree; R Berger
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

5.  The Metabolite Saccharopine Impairs Neuronal Development by Inhibiting the Neurotrophic Function of Glucose-6-Phosphate Isomerase.

Authors:  Ye Guo; Junjie Wu; Min Wang; Xin Wang; Youli Jian; Chonglin Yang; Weixiang Guo
Journal:  J Neurosci       Date:  2022-02-08       Impact factor: 6.709

Review 6.  Progress in understanding 2-hydroxyglutaric acidurias.

Authors:  Martijn Kranendijk; Eduard A Struys; Gajja S Salomons; Marjo S Van der Knaap; Cornelis Jakobs
Journal:  J Inherit Metab Dis       Date:  2012-03-06       Impact factor: 4.982

7.  Saccharopine, a lysine degradation intermediate, is a mitochondrial toxin.

Authors:  João Leandro; Sander M Houten
Journal:  J Cell Biol       Date:  2019-01-16       Impact factor: 10.539

8.  The lysine catabolite saccharopine impairs development by disrupting mitochondrial homeostasis.

Authors:  Junxiang Zhou; Xin Wang; Min Wang; Yuwei Chang; Fengxia Zhang; Zhaonan Ban; Ruofeng Tang; Qiwen Gan; Shaohuan Wu; Ye Guo; Qian Zhang; Fengyang Wang; Liyuan Zhao; Yudong Jing; Wenfeng Qian; Guodong Wang; Weixiang Guo; Chonglin Yang
Journal:  J Cell Biol       Date:  2018-12-20       Impact factor: 10.539

9.  Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.

Authors:  João Leandro; Susmita Khamrui; Chalada Suebsuwong; Peng-Jen Chen; Cody Secor; Tetyana Dodatko; Chunli Yu; Roberto Sanchez; Robert J DeVita; Sander M Houten; Michael B Lazarus
Journal:  Open Biol       Date:  2022-09-21       Impact factor: 7.124

10.  Genetic basis of hyperlysinemia.

Authors:  Sander M Houten; Heleen Te Brinke; Simone Denis; Jos Pn Ruiter; Alida C Knegt; Johannis Bc de Klerk; Persephone Augoustides-Savvopoulou; Johannes Häberle; Matthias R Baumgartner; Turgay Coşkun; Johannes Zschocke; Jörn Oliver Sass; Bwee Tien Poll-The; Ronald Ja Wanders; Marinus Duran
Journal:  Orphanet J Rare Dis       Date:  2013-04-09       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.